Therefore, a study wherein UM cells were treated with a combination of the MEK inhibitor trametinib and the FAK inhibitor VS-4718 showed a synergistic effect on metastatic UM tumor growth in a mouse model [94]. The gene discussed is MAP2K7; the disease is neoplasm.